|
|
|
|
|
|
City of Hope is recognized internationally for its breakthrough research discoveries and clinical treatments for lymphoma and related disorders such as leukemia, myeloma and myelodysplastic syndromes. To learn more about any of our primary lymphoma treatment and research staff, click on their name below.
|
|
|
 | Auayporn P. Nademanee, M.D.
Professor and Associate Clinical Director, Hematology & Hematopoietic Cell Transplantation; Director, Matched Unrelated Donor Program
800-826-HOPE (4673)
|
|
 | Joseph C. Alvarnas, M.D.
Director, Quality Systems for Cellular Therapeutics, Hematology & Hematopoietic Cell Transplantation
800-826-HOPE (4673)
|
|
| |
 | Mark H. Kirschbaum, M.D.
Director, New Drug Development, Hematology & Hematopoietic Cell Transplantation
800-826-HOPE (4673)
|
| |
| |
| |
|
 | Eileen P. Smith, M.D.
Associate Director, Clinical Research, Hematology & Hematopoietic Cell Transplantation
800-826-HOPE (4673)
|
|
|
|
|
|
| | |
| | |
Michael Jensen, M.D.
Associate Professor and Associate Chair, Cancer Immunotherapeutics & Tumor Immunology
800-826-HOPE (4673)
|
| | |
| | |
| |
|
|
|
|
|
|
 To make an appointment for yourself, a family member or a friend, please complete and submit our Become a Patient Request Form, or call City of Hope at 800-826-HOPE (4673). |
|
|